August 10, 2026
Salada Foods Jamaica Limited (SALF)
Unaudited financials for the nine months ended June 30, 2026:
Salada Foods Jamaica Limited (SALF) for the nine months ended June 30, 2026 reported a 12% increase in Revenue totalling $1.28 billion compared to $1.15 billion in the corresponding period last year. Revenue for the third quarter increased by 16% to $443.44 million compared to $381.93 million for the comparable quarter of 2025.
Cost of Sales amounted to $875.59 million (2025: $800.36 million), representing an increase of 9% year over year. Consequently, Gross Profit increased by 16% to $406.63 million compared to $349.47 million for the nine months ended June 30, 2025. Gross Profit for the third quarter amounted to $146.16 million, representing a 30% increase from $112.65 million reported for the corresponding quarter of 2025.
Other Operating Income increased by 11% to $1.37 million from $1.23 million in 2025. Selling and Promotional Expenses increased by 6% to $63.68 million from $60.30 million in the prior year, while Administrative Expenses decreased by 13% to $129.24 million from $148.07 million. As a result, total Administrative, Selling and Promotional Expenses amounted to $192.92 million, representing a 7% decrease relative to $208.37 million reported in 2025.
Operating Profit for the nine months ended June 30, 2026 amounted to $215.08 million, representing a 51% increase from $142.33 million reported in 2025. Operating Profit for the third quarter amounted to $87.35 million, compared to $35.15 million in the corresponding quarter of 2025. Management noted that the improvement was supported by disciplined cost management, improved overhead efficiency and the absence of one-off redundancy costs absorbed in the prior year.
Net Finance Income decreased by 45% to $9.60 million compared to $17.43 million in the prior year. Profit Before Taxation for the nine months ended June 30, 2026 amounted to $224.68 million, representing a 41% increase from $159.76 million reported in 2025. For the third quarter, Profit Before Taxation amounted to $91.03 million, compared to $41.33 million in the corresponding quarter of 2025.
Taxation increased by 41% to $56.17 million compared to $39.94 million in 2025. Consequently, Net Profit for the nine months amounted to $168.51 million, representing a 41% increase from $119.82 million in the prior year. For the third quarter, Net Profit amounted to $68.27 million, compared to $31.00 million in the corresponding quarter of 2025.
Total Comprehensive Income for the nine months amounted to $174.81 million, compared to $119.82 million in 2025. For the third quarter, Total Comprehensive Income amounted to $68.27 million, compared to $26.21 million in the prior year’s quarter.
Consequently, Earnings Per Share for the nine months amounted to $0.16 compared to $0.12 in 2025, while Earnings Per Share for the third quarter amounted to $0.07 compared to $0.03 for the corresponding quarter of 2025. The twelve-month trailing EPS was approximately $0.21, and the number of shares used in these calculations was 1,038,832,900.
Notably, SALF’s stock price closed the trading period on August 7, 2026 at $2.54. Using the twelve-month trailing EPS of approximately $0.21, this represents a P/E ratio of approximately 11.99x.
Balance Sheet Highlights
The company’s Total Assets amounted to $1.58 billion at June 30, 2026, representing a 9% increase from $1.45 billion in 2025. The increase was mainly driven by Cash and Cash Equivalents, which rose to $157.40 million from $68.94 million, as well as Property, Plant and Equipment, which increased to $181.67 million from $115.75 million. Investments also increased to $81.26 million from $74.72 million, while Inventories rose slightly to $530.84 million from $527.81 million.
Shareholders’ Equity increased to $1.25 billion from $1.15 billion in 2025, representing a book value per share of approximately $1.20 compared to $1.11 in the prior year.
Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.
